Literature DB >> 21887518

Altered proportions of naïve, central memory and terminally differentiated central memory subsets among CD4+ and CD8 + T cells expressing CD26 in patients with type 1 diabetes.

Elena Matteucci1, Massimo Ghimenti, Serena Di Beo, Ottavio Giampietro.   

Abstract

Type 1 diabetes is an autoimmune process predominantly T-cell mediated. CD26 plays a role in T-cell costimulation, migration, memory development, thymic maturation and emigration patterns. In peripheral blood from 55 patients with type 1 diabetes and 20 healthy controls, CD4(+) and CD8(+) T cells expressing CD26 were differentiated into naïve (N, CD45RA(+)CCR7(+)), central memory (CM, CD45RA(-)CCR7(+)), effector memory (EM, CD45RA(-)CCR7(-)), and terminally differentiated effector memory (TEMRA, CD45RA(+)CCR7(-)). In type 1 diabetes, CD4(+) and CD8(+) T cells expressing CD26 showed a distinctive differentiation profile: percentages and absolute numbers of CM and N cells were reduced, whereas those of TEMRA cells were markedly increased. The indices of intermediate- and long-term glycaemic control were associated negatively with the number of CM and N cells while positively with the number of TEMRA cells. The considerable accumulation of TEMRA T cells in our patients suggests life-long stimulation by protracted antigen exposure (viruses, other agents or residual self-antigens?) or a homeostatic defect in the regulation/contraction of immune responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887518     DOI: 10.1007/s10875-011-9573-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

Review 1.  Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus.

Authors:  Paolo Monti; Anne-Kristin Heninger; Ezio Bonifacio
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810

2.  Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.

Authors:  Lei Tian; Jie Gao; Jianqiang Hao; Yu Zhang; Huimin Yi; Timothy D O'Brien; Robert Sorenson; Jian Luo; Zhiguang Guo
Journal:  Endocrinology       Date:  2010-05-05       Impact factor: 4.736

3.  Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.

Authors:  Zuzana Mikulkova; Petra Praksova; Pavel Stourac; Josef Bednarik; Lucie Strajtova; Rita Pacasova; Jana Belobradkova; Petr Dite; Jaroslav Michalek
Journal:  Cell Immunol       Date:  2010-02-06       Impact factor: 4.868

4.  Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.

Authors:  J Ilonen; H M Surcel; M L Käär
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM.

Authors:  R A Smerdon; M Peakman; M J Hussain; L Alviggi; P J Watkins; R D Leslie; D Vergani
Journal:  Diabetes       Date:  1993-01       Impact factor: 9.461

Review 6.  Metabolism in T cell activation and differentiation.

Authors:  Erika L Pearce
Journal:  Curr Opin Immunol       Date:  2010-02-26       Impact factor: 7.486

7.  Glucose regulation of dipeptidyl peptidase IV gene expression is mediated by hepatocyte nuclear factor-1alpha in epithelial intestinal cells.

Authors:  Ning Gu; Mariko Tsuda; Tetsuro Matsunaga; Tetsuya Adachi; Koichiro Yasuda; Akihiko Ishihara; Kinsuke Tsuda
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07-29       Impact factor: 2.557

8.  Elevated proportions of recent thymic emigrants in children and adolescents with type 1 diabetes.

Authors:  Johannes Hofer; Sabine Hofer; Manuela Zlamy; Verena Jeller; Christian Koppelstaetter; Anita Brandstätter; Hannelore Kern; Julia Köhle; Lothar Bernd Zimmerhackl; Martina Prelog
Journal:  Rejuvenation Res       Date:  2009-10       Impact factor: 4.663

9.  Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.

Authors:  Su-Jin Kim; Cuilan Nian; Doris J Doudet; Christopher H S McIntosh
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

10.  Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people.

Authors:  Sven Koch; Anis Larbi; Evelyna Derhovanessian; Dennis Ozcelik; Elissaveta Naumova; Graham Pawelec
Journal:  Immun Ageing       Date:  2008-07-25       Impact factor: 6.400

View more
  18 in total

1.  Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression.

Authors:  Tania Habib; S Alice Long; Peter L Samuels; Archana Brahmandam; Megan Tatum; Andrew Funk; Anne M Hocking; Karen Cerosaletti; Michael T Mason; Elizabeth Whalen; David J Rawlings; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2019-03-20       Impact factor: 9.461

2.  CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production.

Authors:  Ryo Hatano; Kei Ohnuma; Junpei Yamamoto; Nam H Dang; Chikao Morimoto
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

3.  A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients.

Authors:  A Oras; A Peet; T Giese; V Tillmann; R Uibo
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

Review 4.  Novel therapies for memory cells in autoimmune diseases.

Authors:  P Bhargava; P A Calabresi
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

5.  Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.

Authors:  K Åkesson; A Tompa; A Rydén; M Faresjö
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

6.  Cytotoxicity-Related Gene Expression and Chromatin Accessibility Define a Subset of CD4+ T Cells That Mark Progression to Type 1 Diabetes.

Authors:  Naiara G Bediaga; Alexandra L Garnham; Gaetano Naselli; Esther Bandala-Sanchez; Natalie L Stone; Joanna Cobb; Jessica E Harbison; John M Wentworth; Annette-G Ziegler; Jennifer J Couper; Gordon K Smyth; Leonard C Harrison
Journal:  Diabetes       Date:  2022-03-01       Impact factor: 9.461

Review 7.  Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.

Authors:  Sherman S Leung; Josephine M Forbes; Danielle J Borg
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

8.  Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.

Authors:  Lei Ding; Conny A Gysemans; Geert Stangé; Yves Heremans; Yixing Yuchi; Tatiana Takiishi; Hannelie Korf; Marie Chintinne; Richard D Carr; Harry Heimberg; Daniel Pipeleers; Chantal Mathieu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.

Authors:  Núria Alonso; María Teresa Julián; Jorge Carrascal; Roger Colobran; Irma Pujol-Autonell; Silvia Rodriguez-Fernández; Aina Teniente; Marco Antonio Fernández; Antoni Miñarro; María Carmen Ruiz de Villa; Marta Vives-Pi; Manel Puig-Domingo
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

Review 10.  T cell recognition of non-peptidic antigens in infectious diseases.

Authors:  Amit Singhal; Lucia Mori; Gennaro De Libero
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.